The evolution of HIV/AIDS infection in Romania 31 December 2017

Similar documents
The evolution of HIV/AIDS Epidemic in Romania 31 December 2013

HIV/AIDS infection in Romania 30 June 2018

Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion

ROMANIA. HIV/AIDS statistical data 30 June 2013

HIV and Paediatrics in Central Europe

HIV infection in children. Mariana Mardarescu MD PhD,

30 years of HIV experience in Romania

STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA

Hepatitis C Burden in Romania Evaluation 2018 Challenges Prof. Adrian Streinu-Cercel MD, PhD, HC

ECDC and Spanish Ministry of Health workshop:

Implementing a priority national health care project in Russian Federation (HIV prevention and treatment)

EDMA HIV-AIDS TEAM Fact Sheet November 2007

Key issues for HIV testing and

ECDC s role in the fight against HIV/AIDS in Europe

ECDC update to the EU Commission Think Tank on HIV/AIDS

Screening programmes for Hepatitis B/C in Europe

HIV-HBV coinfection in HIV population horizontally infected in early childhood between

Program to control HIV/AIDS

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Emerging epidemics: Will they derail progress? Eastern/Central Europe

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

Module 1: HIV epidemiology, transmission and prevention

AIDS was described in June 1981 among homosexuals in the USA, and the virus. HIV/AIDS epidemic features and trends in Saudi Arabia

Annual Epidemiological Report

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Hepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature

Scaling up priority HIV/AIDS interventions in the health sector

UNGASS COUNTRY PROGRESS REPORT Republic of Armenia

Tunisian recommendations on ART : process and results

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Update on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University

Harm reduction among drug users in Spain

Integration of collaborative TB/HIV activities with harm reduction services

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County

Monitoring Recent HIV Infection in Ireland, 2017

Towards universal access

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38

ROMANIA. Country Progress Report on AIDS Reporting period January 2014 December 2014

HIV/AIDS in China. -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA

Improving accessibility to antiretroviral drugs: A south-south collaboration

HIV, HBV and HCV testing policy experiences and lessons learned.

Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians

AIDS Acquired Immune Deficiency Syndrom

Metro St. Louis HIV Epidemiological Profile

HIV/Hepatitis co-infection situation in BALTIC COUNTRIES

Outline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide

JMSCR Vol 3 Issue 10 Page October 2015

Hepatitis B and Hepatitis B Vaccine

Activities in 2010, Priorities for 2011

HIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Romania National Multi-Sectoral HIV/AIDS Commission

Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

Epidemiological Characteristics of HIV/AIDS Pandemic in Romania

2004 Update. Lebanon

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint

HIV-1 Subtypes Circulating in Constanta

Measuring TB burden and access to TB services for people who inject drugs in the WHO European Region, 2010 and 2011

HIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital

HIV Surveillance in Urban and Nonurban Areas. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention

GLOBAL AIDS MONITORING REPORT

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London

STD & HIV ANNUAL REPORT. An Annual Review of HIV and STD s reported in Oakland County, Michigan

2004 Update. Luxembourg

Tuberculosis surveillance in Germany. Data of the tuberculosis report 2013

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah

2004 Update. Georgia

TB/HIV in the WHO European Region Overview, Priorities & Response

Epidemiology and Screening for Hepatitis C Infection

Missouri St. Louis TGA 2016 HIV Epidemiological Profile

Glossary of Terms. Commercial Sex Worker: Self-reported as having received money, drugs or favors in exchange for sex.

2004 Update. Hungary

AN EVALUATION OF HIV CASE-BASED SURVEILLANCE IN IRELAND: DESCRIPTION OF THE SYSTEM, SENSITIVITY AND TIMELINESS. November 2015

Summary: Estimates of HIV Prevalence and Incidence in Canada, 2011

Coding for Preventive Services A Guide for HIV Providers

EPIET REPORT. Background. Fellowship projects

Treat All : From Policy to Action - What will it take?

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT

Epidemiology of blood-borne Infections in Vietnam

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University

HIV/AIDS Epidemiology in Alameda County: State of the County Report

San Francisco Department of Public Health Program Collaboration and Service Integration Surveillance Baseline Assessment

Obstetric Complications in HIV-Infected Women. Jeanne S. Sheffield, MD Maternal-Fetal Medicine UT Southwestern Medical School

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD

Concept note. 1. Background and rationale

Effects of the Global Fund on the health system

Viral Hepatitis in Ireland, 2005

HIV AND HEPATITIS B/C CO-INFECTION IN KWAZULU-NATAL FROM 2002 TO 2010: A RETROSPECTIVE DATABASE ANALYSIS

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

10/07/18. Dr. Otilia Mårdh, ECDC. No conflicts of interest.

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

Strategic Planning for HIV/AIDS

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions

Hepatitis C Cure The Invisible Epidemic

Transcription:

The evolution of HIV/AIDS infection in Romania 31 December 2017

The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS Data and further processed and elaborated by Compartment for Monitoring and Evaluation of HIV/AIDS data in Romania, in National Institute for Infectious Diseases Prof. Dr. Matei Bals

UNAIDS objectives Source: http://www.unaids.org/sites/default/files/media_asset/jc2686_wad2014report_en.pdf

Romania 1985-2017 31 December 2017: 15 009 PLWHA (22 095 cumulative total since 1985). Currently, Romania has a large number of survivors in the 20 29 age group, who belong to the 1987 1990 cohort (>5500). Total no. of patients benefitting from ART and post exposure prophylaxis in 2017 (according to the report released by the Technical Assistance and Management Unit): 12.247 Source: Surveillance Report: HIV/AIDS Surveillance in Europe 2017. ECDC Stockholm Source: Compartment for Monitoring and Evaluation of HIV/AIDS Data in Romania INBI Prof.Dr.M.Balş Rates of new HIV diagnoses, by geographical area and year of diagnosis, WHO European Region, 2007 2016 (including Russia)

Ministry of Health National Institute for Infectious Diseases Prof. Dr. Matei Bals Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania General Data at 31 December 2017 TOTAL HIV/AIDS (CUMULATIVE1985-2017) OF WHICH: 22.980 Total AIDS (Cumulative 1985-2017) 15.587 Total HIV (Cumulative 1992-2017) 7.393 Total no. of AIDS deaths (1985-2017) 714 Out of records HIV/AIDS children + adults 7.257 NUMBER OF PATIENTS LIVING WITH HIV/AIDS OF WHICH: 15.009 0-14 YEARS 196 15-19 YEARS 171 20 YEARS 14.642 New HIV/AIDS cases diagnosed in 2017 692 New HIV cases 399 New AIDS cases 293 HIV/AIDS related deaths, confirmed by medical charts in 2017 171 Total no. of ART and post exposure prophylaxis beneficiaries in 2017 (based on UATM report) 12.247

Distribution of ages Age at date of diagnosis/notification Cumulative total 1985-2017 Distribution by age of PLWHA

AIDS incidence in adults and children between 1985-2017 (100.000) Children 2017: 0.13/100.000 Adults 2017: 1.74/100.000

HIV incidence rate in adults and children between 1985-2017 (100.000) Children 2017: 0.34/100.000 Adults 2017: 2.41/100.000

Distribution of HIV/AIDS cases in PLWHA by age groups and current age at 31 December 2017 (cumulative total 1985-2017) Age group MASCULINE SEX FEMININE TOTAL < 1 year 3 3 6 1-4 yrs. 22 23 45 5-9 yrs. 38 45 83 10-12 yrs. 23 25 48 13-14 yrs. 5 9 14 15-19 yrs. 72 99 171 20-24 yrs. 286 215 501 25-29 yrs. 3289 2747 6036 30-34 yrs. 1358 745 2103 35-39 yrs. 1027 496 1523 40-49 yrs. 1468 932 2400 50-59 yrs. 740 478 1218 60 yrs. 535 326 861 TOTAL 8866 6143 15009

Tendencies in routes of transmission Romania 2007-2017 Route of transmission Vertical** MSM 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 9 (1.91%) 19 (4.03%) 13 (2,33%) 43 (7,71%) 23 (4,14%) 51 (9,18%) 27 (4,7%) 65 (11,32%) 22 (2.81%) 102 (13.04%) 21 (2,3%) 99 (10.86%) 28 (2.89%) 100 (10.34%) 17 (1.87%) 139 (15,35%) 19 (2,27%) 127 (15,19%) 6 (0,78%) 137 (17.97%) 14 (2.02%) 133 (19.21%) IDU (injecting drug use) 6 (1.27%) 4 (0.71%) 11 (1.98%) 17 (2.96%) 153 (19.56%) 283 (31.06%) 290 (29.98%) 187 (20,66%) 164 (19.61%) 118 (15.48%) 106 (15.31%) MSM/IDU 1 (0.21%) 1 (0,18%) 1 (0.17%) 8 (1.02%) 7 (0,76%) 10 (1.03%) 9 (0.99%) 10 (1.19%) 3 (0,39%) 2 (0.28%) Heterosexual 367 (77.91%) 424 (76.12%) 419 (75,49%) 430 (74.91%) 470 (60.1%) 460 (50,49%) 524 (54.18%) 532 (58,78%) 491 (58,73%) 488 (64.04%) 430 (62.13%) Unkown 69 (14.64%) 73 (13.1%) 50 (9%) 34 (5,92%) 27 (3.45%) 41 (4,5%) 15 (1.55%) 21 (2,32%) 25 (2.99%) 10 (1.31%) 7 (1.01%) Total 471 557 555 574 782 911 967 905 836 762 692 *Updating late reporting and case confirmation are performed annually. **New borns perinatally exposed to HIV with HIV positive status in 2017 and perinatally exposed children under surveillance since the previous years

Tendencies in the routes of transmission Romania 2007-2017 Heterosexual IDUs

New HIV/AIDS Cases 1 JANUARY 31 DECEMBER 2017

Distribution of new HIV/AIDS cases by counties - 2017 LEGEND 1 10 21 1 5 6 21 10 1 2 23 1 4 14 16 16 7 9 1 5 CHILDREN (0-14 YEARS) ADULTS (> 14 YEARS) 18 7 3 10 7 15 1 10 7 8 1 7 7 13 10 1 1 10 7 1 252 3 15 1 13 12 3 13 14 37 9

Distribution of new HIV/AIDS cases by sex 2017

Distribution of new HIV/AIDS cases by age group and sex 2017

Distribution of new HIV/AIDS cases by probable routes of transmission Sursa: Compartimentul pentru Monitorizarea şi Evaluarea Infecţiei HIV/SIDA în România INBI Prof.Dr.M.Balş

New HIV/AIDS cases (January-December 2017) through i.v. drug use, by age groups Age group Masculine Feminine Total 15-19 2 2 20-24 8 3 11 25-29 17 4 21 30-34 29 4 33 35-39 21 3 24 40-49 15 2 17 Total 92 16 108

New cases of HIV/AIDS infection through i.v. drug use, by age groups, recorded in 2017

Drugs used by HIV patients (declared by patients), diagnosed in 2017

New HIV/AIDS cases (January-December 2017) through i.v. drug use, by counties County Masculine Feminine Total Brăila 1 1 Bucureşti 73 12 85 Călăraşi 4 4 Galaţi 1 1 Gorj 1 1 Ialomiţa 1 1 Ilfov 5 3 8 Mehedinţi 1 1 Olt 1 1 Sibiu 1 1 Teleorman 1 1 2 Vrancea 2 2 Total 92 16 108

HBV, HCV, STDs in new HIV/AIDS cases through i.v. drug use (100 cases) Tested for Positive % AgHBs 1/108 0,92% VHC 90/108 83.33% AgHBs + VHC 8/108 7.4% STDs 12/108 11.11% TBC 22/108 20.37%

HIV/TB Co-infection in HIV/IDUs, diagnosed in 2017

I.V. drug users diagnosed HIV+ in 2017, previously tested before the current HIV positive test Year of previous testing No.of patients 2017 1 2016 2 2015 3 2014 1 2012 1 2011 2 2010 1 2009 1 2008 1 TOTAL 13

New HIV/AIDS cases registered in the National Data Base: 2009-2017 vs. New HIV/AIDS cases in IDUs registered in the National Data Base: 2009-2017 YEAR 2009 2010 2011 2012 2013 2014 2015 2016 2017 CRITERIA TOTAL of which IDU TOTA L of which IDU TOTAL of which IDU TOTAL of which IDU TOTAL of which IDU TOTAL of which IDU TOTAL of which IDU TOTAL of which IDU TOTAL of which IDU Number of HIV cases 258 6 294 6 408 96 490 158 535 152 485 82 432 61 416 43 399 56 Number of AIDS cases 297 6 280 12 374 63 421 132 432 146 420 114 404 113 346 78 293 52 Total number of HIV/ AIDS cases 555 12 574 18 782 159 911 290 967 298 905 196 836 174 762 121 692 108

HIV testing in IDUs performed by the District Public Health Departments 2007-2017 Year NEGATIVE TEST RESULTS POZITIVE TESTS RESULTS TOTAL % POZITIVE TESTS 2007 620 6 626 0.95% 2008 380 3 383 0.78% 2009 277 6 283 2.12% 2010 96 1 97 1.03% 2011 46 3 49 6.12% 2012 255 19 274 6.93% 2013 106 22 128 20.75% 2014 343 39 382 10.2% 2015 289 8 297 2.7% 2016 271 6 277 2.2% 2017 48 28 76 36.84%

CD4 values in new cases diagnosed in adults - 2017 MASCULINE FEMININE

CD4 values in new HIV/AIDS cases at adults - 2017

CD4 values in new HIV/AIDS cases at adults - 2017 MASCULINE FEMININE

CD4 values in i.v. drug users vs. HIV/AIDS patients with different routes of transmission 2017 IDU Patients with different routes of HIV transmission

CD4 values in IDUs vs. patients who acquired HIV though different ways, detected with HIV/AIDS in 2017 IDUs Pts. with other ways of transmission

Evolution of HIV/AIDS in Romania 1985-2017

AIDS incidence in adults and children between 1985-2017 (100.000) Children 2017: 0.13/100.000 Adults 2017: 1.74/100.000

Sex distribution of AIDS cases at 31 December 2017 (cumulative total 1984-2017)

Age group and sex distribution (at the date of diagnosis) at 31 December 2017 (cumulative total 1985-2017)

Probable way of transmission in children with AIDS (0-14 years at the date of diagnosis) at 31 December 2017 (cumulative total 1989-2017) *Persons who received blood transfusions in the late 1980s and early 1990s. ** Persons with repeated admissions and/or multiple parenteral treatments in the late 1980s and early 1990s

Probable way of transmission in adults with AIDS (>14 years at the date of diagnosis) at 31 December 2017 (cumulative total 1985-2017) * Persons who received blood transfusions in the late 1980s and early 1990s

Distribution of AIDS cases in women, by age group and year of diagnosis, between 1985-2017

HIV incidence rate in adults and children between 1985-2017 (100.000) Children 2017: 0.34/100.000 Adults 2017: 2.41/100.000

Sex distribution of HIV cases at 31 December 2017 (cumulative total 1992-2017)

Age and sex distribution (at the date of diagnosis) of HIV infection cases at 31 December 2017 (cumulative total 1992-2017)

Probable way of transmission in children with HIV infection (0-14 years at the date of diagnosis) at 31 December 2017 (cumulative total 1992-2017) *Persons who received blood transfusions in the late 1980s and early 1990s ** Persons with repeated admissions and/or multiple parenteral treatments in the late 1980s and early 1990s

Probable way of transmission in adults with HIV infection (> 14 years at the date of diagnosis) at 31 December 2017 (cumulative total 1992-2017) *Persons who received blood transfusions in the late 1980s and early 1990s

Distribution of HIV infection in women by years of diagnosis and age group (1992-2017)

HBV, HCV and HBV+HCV infection in seropositive children during 1989-2017

HBV, HCV and HBV+HCV infection in seropositive adults during 1985-2017 Year of diagnosis

AIDS defining illnesses in 2017

Deaths by year 1985-2017

Mean rate of survival (measured in months) in AIDS patients, between 1990-2017 Introduction of ART double therapy Introduction of ART triple therapy Universal access to ART ART as prevention

Mother to child transmission of HIV in Romania

HIV/AIDS Infection in children with mother to child transmission

Age group distribution of HIV/AIDS infection cases acquired through vertical transmission by age group

Children (0-14 years): number of schemes prior to the actual one 31 December 2017

ART schemes in children 31 December 2017

Viral load values in children under antiretroviral treatment

Prophylaxis of mother to child transmission in pregnant women 2009-2017

Prophylaxis of mother to child transmission in children born to HIV positive mothers 2009-2017 Year No. of born children No. of prophylaxis 2009 204 192 2010 222 204 2011 196 183 2012 203 196 2013 239 230 2014 215 211 2015 220 213 2016 230 227 2017 214 212

HIV testing 2017

HIV testing* in risk groups in 2017 Risk group Negative tests Positive tests TOTAL %POZITIV STD 1054 22 1076 2.09 TBC 9986 78 10064 0.78 Maternity testing 481 14 495 2.91 Pregnant women 126897 143 127040 0.11 Health care staff 10438 0 10438 0.00 Pts. with hemodialysis 3819 0 3819 0.00 Pts. with transfusions 49 0 49 0.00 Prenuptial check-up 7266 4 7270 0.06 I.V. drug users 48 28 76 58.33 Inmates 163 0 163 0.00 Homosexuals 11 4 15 36.36 Commercial sex workers 19 0 19 0.00 HIV Contacts 761 129 890 16.95 Sailors 6035 4 6039 0.07 Drivers 11789 3 11792 0.03 Work abroad> 6 month 361 2 363 0.55 Stay abroad> 6 month 79 5 84 6.33 Testing by request 114951 642 115593 0.56 Occasional 42760 853 43613 1.99 TOTAL 336967 1931 338898 0.57 * The data are sent by County Public Health Authorities

HIV testing in pregnant women, by age group in 2017 Age group Negative tests Positive tests TOTAL %Positive 12-14 yrs. 649 3 652 0.46 15-19 yrs. 13786 18 13804 0.13 20-24 yrs. 26315 18 26333 0.07 25-29 yrs. 36848 76 36924 0.21 30-34 yrs. 28231 19 28250 0.07 35-39 yrs. 14407 7 14414 0.05 > 40 yrs. 4105 4105 0.00 Unspecified age 2556 2 2558 0.08 TOTAL 126897 143 127040 0.11 * The data are sent by County Public Health Authorities

HIV testing in pregnant women by age group in 2017

Total testing Positive tests HIV testing in pregnant women Year

HIV testing in blood donors Year

STD testing in HIV patients Year

HIV testing in TB patients Year

HIV testing in HIV contacts Year

HIV testing by request Year

Challenges in 2017...

Source : A. Streinu-Cercel. cnlas.ro: Specific Challenges of the HIV Epidemic in Romania. EACS 2013. M. Mardarescu. Et All. Risk factors involved in late detection of HIV mother to child transmission - data from the National Registry of HIV pregnant women and perinatally exposed children in Romania. 2 nd Vilnius Summit on Communicable Diseases. Oct 4-7, 2017. 14 th Congress of the BADV, October 5-7, 2017. Vilnius, Lithuania. CURRENT SITUATION Romania 2017 PLWHA MTCT ART IDUs Young by age, old by treatment Therapeutic fatigue New HIV infection cases: young people in their fertile age, late presentations in the sanitary system. MSM: increase of the number in dynamics Increase in HIV cases in adults. Young mothers, with multiple therapeutic schemes Mothers with unknown HIV status- recommendation for HIV testing and specific ART treatment New approach of HIV peinatalally exposed new bourns management. National Registry of HIV perinatally exposed children and of women infected with HIV. Most ARTs- available in Romania Universal access to treatment. Treatment introduction regardless of CD4 count. Treatment as prevention. Sub-optimal regimen during the first weeks of life Management of ART toxicity ART approach in young women living with HIV/AIDS New psychoactive substances. New approach of mothers who uses drugs and of new- bourns, perinatally exposed to HIV.

CURRENT SITUATION Romania 2017 Tx Fatigue Comorbidities Aging Future challenges? Long term therapy + many therapeutic schemes + many VF + immunologic failure A lot of co-morbidities Important implication from DDI point of view New approaches, New mechanism New understandings New attitude New outcomes Source : A. Streinu-Cercel. cnlas.ro: Specific Challenges of the HIV Epidemic in Romania. EACS 2013. M. Mardarescu. Et All. Risk factors involved in late detection of HIV mother to child transmission - data from the National Registry of HIV pregnant women and perinatally exposed children in Romania. 2 nd Vilnius Summit on Communicable Diseases. Oct 4-7, 2017. 14 th Congress of the BADV, October 5-7, 2017. Vilnius,

Global HIV/AIDS infection 2016

Source: UNAIDS - Jully 2017

million Source: UNAIDS - Jully 2017 Estimates on the number of PLWHA (2000-2016)

Source: UNAIDS - Jully 2017

Source: UNAIDS - Jully 2017

Source: UNAIDS - Jully 2017

Source: UNAIDS - Jully 2017

Source: UNAIDS - Jully 2017

Source: UNAIDS - Jully 2017

Characteristics of HIV infection cases diagnosed in the WHO European Region in 2016, by geographical areas WHO European Region West Centre East EU/EEA countrie s Reporting countries/no. of reporting countries* 50/53 (51/53) 23/23 15/15 12/15 (13/15) 31/31 Number of HIV infection cases 57 015 (160 453) 26 602 5772 24 641 (128 079) 29 444 Rate per 100.000 population 7.7 (18.2) 6.2 2.9 22.1 (50.2) 5.9 % of cases: 15-24 age group 9.4% 10.2% 14.8% 7.1% 10.6% Percentage age 50+ years 15.6% 19.6% 12.1% 12.2% 18.5% Men/women ration 2.3 3.1 5.9 1.5 3.2 Way of transmssion Heterosexual 46.8% 32.9% 27.0% 66.4% 32.3% MSM 23.9% 41.3% 29.9% 3.7% 40.1% I.V. drugs 12.5% 2.9% 2.7% 25.2% 3.6% MTCT 0.7% 0.5% 0.5% 0.9% 0.5% Unknown 16.0% 22.1% 39.7% 3.8% 23.2% * No data received from Russia, Turkmenistan, Uzbekistan. All data presented were reported to ECDC/WHO through the European Surveillance System (TESSy), except for data for Russia which were obtained through the Russian Federal Scientific and Methodological Center for Prevention and Control of AIDS [1]. Russian data are included in the numbers in parentheses for the European Region and the East. ** EU/EEA rate is adjusted for reporting delay (Annex 5), the corresponding estimated number of new diagnoses adjusted for reporting delay is 30 523 Source: HIV/AIDS Surveillance in Europe 2017; https://ecdc.europa.eu/sites/portal/files/documents/20171127-annual_hiv_report_cover%2binner.pdf

CASE DEFINITIONS OF COMMUNICABLE DISEASES ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION Clinical Criteria (AIDS) Any person who has any of the clinical conditions as defined in the European AIDS case definition for: Adults and adolescents 15 years Children < 15 years of age Laboratory Criteria (HIV) Adults, adolescents and children aged 18 months At least one of the following three: Positive result of a HIV screening antibody test or a combined screening test (HIV antibody and HIV p24 antigen) confirmed by a more specific antibody test (e.g. Western blot) Positive result of 2 EIA antibody test confirmed by a positive result of a further EIA test Positive results on two separate specimens from at least one of the following three: Detection of HIV nucleic acid (HIV-RNA. HIV-DNA) Demonstration of HIV by HIV p24 antigen test. including neutralisation assay Isolation of HIV Children aged < 18 months Positive results on two separate specimens (excluding cord blood) from at least one of the following three: Isolation of HIV Detection of HIV nucleic acid (HIV-RNA. HIV-DNA) Demonstration of HIV by HIV p24 antigen test. including neutralisation assay in a child 1 month of age http://eur-lex.europa.eu/lexuriserv/lexuriserv.do?uri=consleg:2002d0253:20120927:en:pdf eur-lex.europa.eu/lexuriserv/lexuriserv.do?uri=consleg:2002d0253:20120927:en:pdf

Epidemiological Criteria NA Case Classification A. Possible case NA B. Probable case NA C. Confirmed case HIV infection Any person meeting the laboratory criteria for HIV infection AIDS Any person meeting the clinical criteria for AIDS and the laboratory criteria for HIV infection http://eur-lex.europa.eu/lexuriserv/lexuriserv.do?uri=consleg:2002d0253:20120927:en:pdf

Definitions INCIDENCE = Number of new cases of infection X 100.000 population. registered at 1 July 2017 PREVALENCE = Number of new and old cases of infection X 100.000 population. registered at 1 July 2017

Sources and references Commission Decision of 28/IV/2008 amending Decision 2002/253/Ec laying down case definitions for reporting communicable diseases to the Community network under Decision no 2119/98/EC of the European Parliament and Council http://eurlex.europa.eu/lexuriserv/lexuriserv.do?uri=consleg:2002d0253:201 20927:EN:PDF

National Institute for Infectious Diseases Prof. Dr. Matei Bals Compartment for Monitoring and Evaluation of HIV/AIDS Data in Romania Manager: Prof.Dr. Adrian Streinu-Cercel Head of Infectious Diseases UMF Carol Davila Coordinator: Coordinator Adults Programme: Coordinator Children Programme: Mariana Mărdărescu MD PhD Associated Proffesor Elisabeta Otilia Benea MD PhD Sorin Petrea MD Statistical data operators : PC Operators: Epidemiology: As.med. Marieta Iancu Daniela Viţelaru Sanda Vintilă Ionel Iosif MD